Radiant Innovation - Asset Resilience Ratio

Latest as of December 2025: 1.04%

Radiant Innovation (3373) has an Asset Resilience Ratio of 1.04% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$8.94 Million
≈ $281.75K USD Cash + Short-term Investments

Total Assets

NT$861.31 Million
≈ $27.14 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Radiant Innovation's Asset Resilience Ratio has changed over time. Check how strategically is Radiant Innovation's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Radiant Innovation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Radiant Innovation stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$8.94 Million 1.04%
Total Liquid Assets NT$8.94 Million 1.04%

Asset Resilience Insights

  • Limited Liquidity: Radiant Innovation maintains only 1.04% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Radiant Innovation Industry Peers by Asset Resilience Ratio

Compare Radiant Innovation's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Stratec SE
XETRA:SBS
Medical Devices 0.30%
T&R Biofab Co. Ltd
KQ:246710
Medical Devices 0.12%
Hironic Co. Ltd
KQ:149980
Medical Devices 17.42%
Novacyt
PA:ALNOV
Medical Devices 0.02%
Implanet SA
PA:ALIMP
Medical Devices 0.55%
Adherium Ltd
AU:ADR
Medical Devices 15.45%

Annual Asset Resilience Ratio for Radiant Innovation (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Radiant Innovation.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.04% NT$8.94 Million
≈ $281.75K
NT$861.31 Million
≈ $27.14 Million
-0.13pp
2024-12-31 1.17% NT$10.95 Million
≈ $344.86K
NT$935.42 Million
≈ $29.47 Million
-0.16pp
2023-12-31 1.33% NT$13.01 Million
≈ $409.76K
NT$979.30 Million
≈ $30.85 Million
+0.14pp
2022-12-31 1.18% NT$13.23 Million
≈ $416.75K
NT$1.12 Billion
≈ $35.18 Million
+0.13pp
2021-12-31 1.05% NT$13.03 Million
≈ $410.36K
NT$1.24 Billion
≈ $39.07 Million
+0.14pp
2020-12-31 0.91% NT$17.46 Million
≈ $550.05K
NT$1.92 Billion
≈ $60.64 Million
-3.15pp
2017-12-31 4.06% NT$32.66 Million
≈ $1.03 Million
NT$804.84 Million
≈ $25.36 Million
--
pp = percentage points

About Radiant Innovation

TWO:3373 Taiwan Medical Devices
Market Cap
$24.15 Million
NT$766.66 Million TWD
Market Cap Rank
#24434 Global
#1530 in Taiwan
Share Price
NT$16.10
Change (1 day)
+0.31%
52-Week Range
NT$16.05 - NT$20.65
All Time High
NT$110.75
About

Radiant Innovation Inc. engages in the design and development of infrared technology products in Taiwan, Japan, and Germany. It offers medical infrared thermometers, including infrared ear, non-contact forehead, and multi-function thermometers, as well as probe cover; and CO2 monitors. The company also offers industrial infrared thermometers, infrared precision thermal imagers, infrared precision… Read more